{"nctId":"NCT00396097","briefTitle":"Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature","startDateStruct":{"date":"2006-12"},"conditions":["Idiopathic Short Stature"],"count":316,"armGroups":[{"label":"Standard","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Genotropin"]},{"label":"Formula-based","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Genotropin"]}],"interventions":[{"name":"Genotropin","otherNames":[]},{"name":"Genotropin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Prepubertal children with bone ages between 3 and 10 years of age for males and 3 and 9 years of age for females\n* Naive to Growth Hormone treatment\n\nExclusion Criteria:\n\n* Abnormal karyotype. Small Gestational Age and Skeletal dysplasia.","healthyVolunteers":false,"sex":"ALL","minimumAge":"3 Years","maximumAge":"10 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Absolute On-target Difference (AOTD) at 24 Months","description":"This was defined as an absolute difference between the 24-month height standard deviation score (SDS) and targeted 24-month height SDS (10th percentile (%), or -1.3 SDS). SDS indicates how similar the participant was to the reference population. These were calculated using 2000 Center for the Disease Control (CDC) growth reference tables (by age and gender).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.603","spread":"0.2948"},{"groupId":"OG001","value":"0.625","spread":"0.3003"}]}]}]},{"type":"SECONDARY","title":"Variability of Height SDS at 24 Months","description":"The continuous endpoint of variability of height SDS at 24 months was defined as the SD of the 24 month height SDS.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.12","spread":"0.408"},{"groupId":"OG001","value":"1.11","spread":"0.518"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.03","spread":"0.475"},{"groupId":"OG001","value":"1.04","spread":"0.544"}]}]}]},{"type":"SECONDARY","title":"Time Cost (Months Until >= -2 SDS)","description":"Time cost was defined as the number of months needed until height SDS was within the normal limit (ie, \\>= -2SDS).","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.00","spread":null},{"groupId":"OG001","value":"12.00","spread":null}]}]}]},{"type":"SECONDARY","title":"Computed Cost of Height Gain at 48 Months","description":"The computed cost of height gain was defined as the amount of drug used relative to the observed height-gain, in terms of mg/cm, this was calculated at Month 48.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.77","spread":"17.914"},{"groupId":"OG001","value":"67.30","spread":"24.382"},{"groupId":"OG002","value":"63.07","spread":"21.656"},{"groupId":"OG003","value":"69.62","spread":"21.903"}]}]}]},{"type":"SECONDARY","title":"Estimated Cost of Height Gain Estimated Until Full Adult Height (FAH) at 48 Months","description":"The estimated cost of long-term height gain until FAH was calculated.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"127.99","spread":"29.708"},{"groupId":"OG001","value":"91.34","spread":"31.854"},{"groupId":"OG002","value":"80.06","spread":"21.000"},{"groupId":"OG003","value":"92.24","spread":"25.213"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Height SDS at 48 Months.","description":"Change in height SDS was measured at 48 months.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.33","spread":"0.717"},{"groupId":"OG001","value":"1.24","spread":"0.668"},{"groupId":"OG002","value":"1.33","spread":"0.637"},{"groupId":"OG003","value":"1.34","spread":"0.633"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":13,"n":118},"commonTop":["Headache","Upper respiratory tract infection","Pharyngitis streptococcal","Arthralgia","Influenza"]}}}